Experimental pill nearly doubles survival time for people with advanced pancreatic cancer. 'I actually started crying' | Fortune

The drug is called daraxonrasib and it blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases — a target that had eluded treatment for decades.

Raccontata dapbs.orgmedpagetoday.comnbcnews.comindependent.co.uktheguardian.comdailymail.commirror.co.ukcbsnews.comfortune.comcnn.comdailysabah.cominews.co.uk+5 altre